Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.

E. Lankford(Hospital of the University of Pennsylvania), H. Lee Sweeney(University of Pennsylvania), Nava Epstein(Sheba Medical Center), Lameh Fananapazir(National Heart Lung and Blood Institute)

Journal of Clinical Investigation

March 1, 1995

10.1172/jci117795

Cited by 182

Related Papers

Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.

|The EMBO Journal|1991|774

Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

|Circulation|1994|383

Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

|Journal of Clinical Investigation|1993|242

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

|Circulation|1992|230

Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.

|Circulation|1994|226